{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:03:00Z","timestamp":1793196180088,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Guidelines recommend deprescribing opioids in older adults due to risk of adverse effects, yet little is known about patient-clinician opioid deprescribing conversations.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To understand the experiences of older adults and primary care practitioners (PCPs) with using opioids for chronic pain and discussing opioid deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This qualitative study conducted semistructured individual qualitative interviews with 18 PCPs and 29 adults 65 years or older prescribed opioids between September 15, 2022, and April 26, 2023, at a Boston-based academic medical center. The PCPs were asked about their experiences prescribing and deprescribing opioids to older adults. Patients were asked about their experiences using and discussing opioid medications with PCPs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n Shared and conflicting themes between patients and PCPs regarding perceptions of opioid prescribing and barriers to deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In total, 18 PCPs (12 [67%] younger that 50 years; 10 [56%] female; and 14 [78%] based at an academic practice) and 29 patients (mean [SD] age, 72 [5] years; 19 [66%] female) participated. Participants conveyed that conversations between PCPs and patients on opioid use for chronic pain were typically challenging and that conversations regarding opioid risks and deprescribing were uncommon. Three common themes related to experiences with opioids for chronic pain emerged in both patient and PCP interviews: opioids were used as a last resort, opioids were used to improve function and quality of life, and trust was vital in a clinician-patient relationship. Patients and PCPs expressed conflicting views on risks of opioids, with patients focusing on addiction and PCPs focusing on adverse drug events. Both groups felt deprescribing conversations were often unsuccessful but had conflicting views on barriers to successful conversations. Patients felt deprescribing was often unnecessary unless an adverse event occurred, and many patients had prior negative experiences tapering. The PCPs described gaps in knowledge on how to taper, a lack of clinical access to monitor patients during tapering, and concerns about patient resistance.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this qualitative study, PCPs and older adults receiving long-term opioid therapy viewed the use of opioids as a beneficial last resort for treating chronic pain but expressed dissonant views on the risks associated with opioids, which made deprescribing conversations challenging. Interventions, such as conversation aids, are needed to support collaborative discussion about deprescribing opioids.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.1342","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T11:01:08Z","timestamp":1709722868000},"page":"e241342","source":"Crossref","is-referenced-by-count":39,"title":["Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain"],"prefix":"10.1001","volume":"7","author":[{"given":"Timothy S.","family":"Anderson","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Center for Pharmaceutical Policy and Prescribing, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna X.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Lindenberg","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana J.","family":"Herzig","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan M.","family":"Berens","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara A.","family":"Schonberg","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"36","key":"zoi240076r1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults\u2014United States, 2016.","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi240076r2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi240076r3","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/jgs.2009.57.issue-8","article-title":"Pharmacological management of persistent pain in older persons.","volume":"57","author":"American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi240076r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"zoi240076r5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids.","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"zoi240076r6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events.","volume":"103","author":"Mark","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"zoi240076r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008-2017.","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi240076r8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline.","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"19","key":"zoi240076r9","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2019.16409","article-title":"Patient-centered reduction or discontinuation of long-term opioid analgesics: the HHS guide for clinicians.","volume":"322","author":"Dowell","year":"2019","journal-title":"JAMA"},{"issue":"15","key":"zoi240076r11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s40265-020-01368-y","article-title":"Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials.","volume":"80","author":"Mathieson","year":"2020","journal-title":"Drugs"},{"issue":"11","key":"zoi240076r12","article-title":"Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.","volume":"11","author":"Eccleston","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"zoi240076r13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40266-023-01071-z","article-title":"Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing.","volume":"40","author":"Kelley","year":"2023","journal-title":"Drugs Aging"},{"issue":"11","key":"zoi240076r14","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/j.pain.0000000000002270","article-title":"\u201cThe lesser of two evils\u201d: a framework analysis of consumers\u2019 perspectives on opioid deprescribing and the development of opioid deprescribing guidelines.","volume":"162","author":"Langford","year":"2021","journal-title":"Pain"},{"issue":"12","key":"zoi240076r15","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1016\/j.sapharm.2022.07.043","article-title":"Opioid deprescribing: qualitative perspectives from those with chronic non-cancer pain.","volume":"18","author":"Hamilton","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"zoi240076r16","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1097\/j.pain.0000000000002340","article-title":"Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.","volume":"163","author":"Hamilton","year":"2022","journal-title":"Pain"},{"issue":"2","key":"zoi240076r17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","article-title":"Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.","volume":"30","author":"Langford","year":"2021","journal-title":"BMJ Qual Saf"},{"issue":"6","key":"zoi240076r18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.","volume":"24","author":"Krebs","year":"2009","journal-title":"J Gen Intern Med"},{"key":"zoi240076r20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions.","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"11","key":"zoi240076r22","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/add.2010.105.issue-11","article-title":"Using theories of behaviour change to inform interventions for addictive behaviours.","volume":"105","author":"Webb","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"zoi240076r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066234","article-title":"Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) model: a qualitative study.","volume":"13","author":"Keller","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"zoi240076r24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial.","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"zoi240076r25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/jgs.v71.5","article-title":"Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics.","volume":"71","author":"Gray","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"zoi240076r26","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s11606-022-07880-z","article-title":"Patient and provider perspectives on benefits and harms of continuing, tapering, and discontinuing long-term opioid therapy.","volume":"38","author":"Nevedal","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"8","key":"zoi240076r27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jamaoncol.2020.2211","article-title":"Changes in opioid prescribing patterns among generalists and oncologists for Medicare Part D beneficiaries from 2013 to 2017.","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"zoi240076r28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"zoi240076r29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jamainternmed.2023.2847","article-title":"Centers for Disease Control and Prevention guideline for prescribing opioids, 2022\u2014need for integrating dosing benchmarks with shared decision-making.","volume":"183","author":"Sullivan","year":"2023","journal-title":"JAMA Intern Med"},{"key":"zoi240076r30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11606-020-06254-7","article-title":"Promoting patient-centeredness in opioid deprescribing: a blueprint for de-implementation science.","volume":"35","author":"Kertesz","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"5-6","key":"zoi240076r31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/fampra\/cmad058","article-title":"Pragmatic Delphi study aimed at determining practical components for a tool designed to assist Dutch primary care-givers in opioid deprescribing for non-cancer pain.","volume":"40","author":"Jansen-Groot Koerkamp","year":"2023","journal-title":"Fam Pract"},{"issue":"2","key":"zoi240076r32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5694\/mja2.v219.2","article-title":"Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.","volume":"219","author":"Langford","year":"2023","journal-title":"Med J Aust"},{"issue":"4","key":"zoi240076r33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40266-023-01011-x","article-title":"TANGO: development of consumer information leaflets to support tapering of opioids in older adults with low back pain and hip and knee osteoarthritis.","volume":"40","author":"Marcelo","year":"2023","journal-title":"Drugs Aging"},{"key":"zoi240076r21","volume-title":"Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory","author":"Strauss","year":"1998","edition":"2nd ed"},{"key":"zoi240076r10","unstructured":"Agency for Healthcare Research and Quality. Opioid use among elderly & non-elderly adults by socioeconomic characteristics. July 2022. Accessed Sept 22, 2023. https:\/\/www.ahrq.gov\/opioids\/data\/online-resources\/opioids-elderly-nonelderly.html"},{"key":"zoi240076r19","unstructured":"US Deprescribing Research Network. Stakeholder engagement council. Accessed October 16, 2023. https:\/\/deprescribingresearch.org\/stakeholder-engagement-council\/"},{"key":"zoi240076r34","unstructured":"Centers for Medicare & Medicaid Services. Calendar Year (CY) 2023 Medicare physician fee schedule final rule. November 1, 2022. Accessed September 22, 2023. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/calendar-year-cy-2023-medicare-physician-fee-schedule-final-rule"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815766\/anderson_2024_oi_240076_1708699215.08874.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T11:01:11Z","timestamp":1709722871000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1342","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}